Author/Authors :
Belkacemi, Yazid Department of Radiation Oncology and Henri Mondor Breast Cancer Center - Créteil, France , Salmon, Remy Department of Breast Surgery - Les Peupliers Clinic - Paris, France , Russell, Nicola Department of Radiotherapy - The Netherlands Cancer Institute - Amsterdam, Netherlands
Abstract :
Predicting breast cancer (BC) outcome based on
sentinel lymph node (SLN) status without axillary
lymph node dissection (ALND) is an area of
uncertainty in patients with limited SLN
involvement. These uncertainties automatically
influence the decision-making on adjuvant regional
nodal irradiation (RNI). The updated clinical
practice guidelines report from the American
Society of Clinical Oncology on the use of SLN for
patients with early-stage BC concluded that women
without SLN metastases and those with 1-2
metastatic SLNs receiving whole breast irradiation
(WBI) should not undergo ALND
